$HRGN
Harvard Apparatus Regenerative Technology Inc

2015 Q1 Form 10-K Financial Statement

#000114420415018746 Filed on March 27, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 2013 Q4
Revenue $0.00 $93.00K $22.00K
YoY Change -100.0% 322.73%
Cost Of Revenue $0.00 $48.00K $11.00K
YoY Change -100.0% 336.36%
Gross Profit $0.00 $45.00K $11.00K
YoY Change -100.0% 309.09%
Gross Profit Margin 48.39% 50.0%
Selling, General & Admin $1.378M $5.983M $1.580M
YoY Change -23.44% 40.25% 64.58%
% of Gross Profit 13295.56% 14363.64%
Research & Development $1.242M $5.119M $1.080M
YoY Change 2.05% 12.21% 8.0%
% of Gross Profit 11375.56% 9818.18%
Depreciation & Amortization $112.0K $363.0K $40.00K
YoY Change 100.0% 129.75% 100.0%
% of Gross Profit 806.67% 363.64%
Operating Expenses $2.620M $11.10M $2.659M
YoY Change -13.16% 25.76% 35.25%
Operating Profit -$2.620M -$11.06M -$2.648M
YoY Change -12.84% 25.41% 34.69%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$3.000K -$4.000K $0.00
YoY Change
Pretax Income -$2.623M -$11.06M -$2.648M
YoY Change -12.74% 25.45% 34.42%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.623M -$11.06M -$2.648M
YoY Change -12.74% 25.45% 34.42%
Net Earnings / Revenue -11893.55% -12036.36%
Basic Earnings Per Share
Diluted Earnings Per Share -$5.955M -$28.29M -$6.795M
COMMON SHARES
Basic Shares Outstanding 10.07M shares 7.740M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.16M $5.272M $14.01M
YoY Change -3.57% -62.37%
Cash & Equivalents $12.16M $14.01M
Short-Term Investments
Other Short-Term Assets $270.0K $317.0K $0.00
YoY Change -22.86% -24.52%
Inventory $210.0K $0.00 $38.00K
Prepaid Expenses $269.0K $421.0K
Receivables $0.00 $5.000K
Other Receivables $0.00 $27.00K
Total Short-Term Assets $12.65M $5.828M $14.49M
YoY Change -3.44% -59.78%
LONG-TERM ASSETS
Property, Plant & Equipment $1.269M $1.376M $575.0K
YoY Change 66.97% 137.24% 31.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.269M $1.376M $575.0K
YoY Change 66.97% 141.4% 31.28%
TOTAL ASSETS
Total Short-Term Assets $12.65M $5.828M $14.49M
Total Long-Term Assets $1.269M $1.376M $575.0K
Total Assets $13.92M $7.204M $15.06M
YoY Change 0.42% -52.16% 3339.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $261.0K $370.0K $244.0K
YoY Change -36.34% 54.17% 36.31%
Accrued Expenses $400.0K $324.0K $160.0K
YoY Change 33.33% 102.5% -30.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $674.0K $710.0K $495.0K
YoY Change -22.53% 42.0% 20.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $674.0K $710.0K $495.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $674.0K $710.0K $495.0K
YoY Change -22.53% 42.0% 20.44%
SHAREHOLDERS EQUITY
Retained Earnings -$15.66M -$1.974M
YoY Change 214.42%
Common Stock $101.0K $77.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.24M $6.494M $14.57M
YoY Change
Total Liabilities & Shareholders Equity $13.92M $7.204M $15.06M
YoY Change 0.43% -52.16% 3339.27%

Cashflow Statement

Concept 2015 Q1 2014 2013 Q4
OPERATING ACTIVITIES
Net Income -$2.623M -$11.06M -$2.648M
YoY Change -12.74% 25.45% 34.42%
Depreciation, Depletion And Amortization $112.0K $363.0K $40.00K
YoY Change 100.0% 129.75% 100.0%
Cash From Operating Activities -$1.690M -$7.993M -$2.090M
YoY Change 19.86% 3.94% 36.6%
INVESTING ACTIVITIES
Capital Expenditures $6.000K $1.164M -$150.0K
YoY Change -97.52% 294.58% -6.25%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$10.00K -$1.164M -$150.0K
YoY Change -95.83% 288.0% -6.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.237M $420.0K
YoY Change 1210.53% 13900.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.590M 420.0K 16.25M
YoY Change 3336.0% -98.09% 861.54%
NET CHANGE
Cash From Operating Activities -1.690M -7.993M -2.090M
Cash From Investing Activities -10.00K -1.164M -150.0K
Cash From Financing Activities 8.590M 420.0K 16.25M
Net Change In Cash 6.890M -8.737M 14.01M
YoY Change -592.14% -162.41%
FREE CASH FLOW
Cash From Operating Activities -$1.690M -$7.993M -$2.090M
Capital Expenditures $6.000K $1.164M -$150.0K
Free Cash Flow -$1.696M -$9.157M -$1.940M
YoY Change 2.66% 14.68% 41.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
317000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
207000 USD
CY2014Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
27000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
575000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1376000 USD
CY2014Q4 us-gaap Assets
Assets
7204000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
370000 USD
CY2014Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
16000 USD
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
324000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
710000 USD
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2014Q4 us-gaap Liabilities
Liabilities
710000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16466000 USD
CY2014Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1376000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
14569000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15064000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
5828000 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4007000 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5654000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5119000 USD
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
575000 USD
CY2013Q4 us-gaap Assets
Assets
15064000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
244000 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
90000 USD
CY2013Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
161000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
495000 USD
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2013Q4 us-gaap Liabilities
Liabilities
495000 USD
CY2013Q4 us-gaap Cash
Cash
14008000 USD
CY2013Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
22000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1974000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13035000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
6494000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
77000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
79000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19449000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7204000 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY:Times New Roman, Times, Serif"><b><i> (b)</i></b></font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY:Times New Roman, Times, Serif"><b><i>Use of Estimates</i></b></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" align="left">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0.25in" align="left">The process of preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates include, but are not limited to, stock-based compensation, accruals, depreciation and income taxes. Actual results could differ from those estimates and changes in estimates may occur.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2680000 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2648000 USD
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7742080 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7856607 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7742080 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7856607 shares
CY2013Q4 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
15000000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
31000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
207000 USD
CY2013Q4 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2000000 USD
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
281000 USD
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
449000 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
388000 USD
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1138000 USD
CY2013Q4 hart Computer Equipment And Software
ComputerEquipmentAndSoftware
154000 USD
CY2014Q4 hart Computer Equipment And Software
ComputerEquipmentAndSoftware
400000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
823000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1987000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
248000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
611000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
97000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
41000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
138000 USD
CY2013 us-gaap Revenues
Revenues
22000 USD
CY2014 us-gaap Revenues
Revenues
93000 USD
CY2013 us-gaap Cost Of Revenue
CostOfRevenue
11000 USD
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
48000 USD
CY2013 us-gaap Gross Profit
GrossProfit
11000 USD
CY2014 us-gaap Gross Profit
GrossProfit
45000 USD
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
259000 USD
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
329000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4562000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
8828000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
11102000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-8817000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-11057000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-8817000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-11061000 USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.14
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.41
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7740000 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7821000 shares
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
44776 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
94962 USD
CY2014 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-05-31
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2998000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
2565000 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3761000 USD
CY2013 hart Income Tax Reconciliation Pre Separation Losses
IncomeTaxReconciliationPreSeparationLosses
2327000 USD
CY2014 hart Income Tax Reconciliation Pre Separation Losses
IncomeTaxReconciliationPreSeparationLosses
0 USD
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
13000 USD
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
40000 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-118000 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-663000 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
18000 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
94000 USD
CY2013 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
-50000 USD
CY2014 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
-178000 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
808000 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4468000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-8602000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10780000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-215000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-281000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8817000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11061000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
514000 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2543000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
294000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1086000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
808000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5277000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
808000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5277000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
84000 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
90000 USD
CY2013Q1 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
In March of 2013, the Company performed an 80,000-for-1 stock split to achieve a desired 8 million shares outstanding.
CY2013Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
Immediately prior to the Distribution on October 31, 2013 HART affected a reverse stock split so that shares outstanding became 7.7 million to facilitate the 1-for-4 ratio for the Distribution. The distribution of the 7.7 million HART common shares to the shareholders of Harvard Bioscience is reflected as an issuance of common stock in the consolidated statements of stockholders equity.
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85 pure
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
150000 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
27000 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15758000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1370000 USD
CY2013 hart Net Funds Provided By Parent Company
NetFundsProvidedByParentCompany
6228000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
420000 USD
CY2013 hart Shares Issued During Period Value Vesting Of Restricted Stock Units
SharesIssuedDuringPeriodValueVestingOfRestrictedStockUnits
0 USD
CY2014 hart Shares Issued During Period Value Vesting Of Restricted Stock Units
SharesIssuedDuringPeriodValueVestingOfRestrictedStockUnits
0 USD
CY2014 hart Percentage Of Option Lost Value Allocated To Parent Company Options
PercentageOfOptionLostValueAllocatedToParentCompanyOptions
0.8 pure
CY2014 hart Percentage Of Option Lost Value Allocated To Stock Options
PercentageOfOptionLostValueAllocatedToStockOptions
0.2 pure
CY2013Q1 us-gaap Revenues
Revenues
0 USD
CY2014Q1 us-gaap Revenues
Revenues
23000 USD
CY2013Q2 us-gaap Revenues
Revenues
0 USD
CY2014Q2 us-gaap Revenues
Revenues
23000 USD
CY2013Q3 us-gaap Revenues
Revenues
0 USD
CY2014Q3 us-gaap Revenues
Revenues
2000 USD
CY2013Q4 us-gaap Revenues
Revenues
22000 USD
CY2014Q4 us-gaap Revenues
Revenues
45000 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
12000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
12000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
1000 USD
CY2013Q4 us-gaap Cost Of Revenue
CostOfRevenue
11000 USD
CY2014Q4 us-gaap Cost Of Revenue
CostOfRevenue
23000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
0 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
11000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
0 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
11000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
0 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
1000 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
11000 USD
CY2014Q4 us-gaap Gross Profit
GrossProfit
22000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
2020000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
3017000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
2089000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
2544000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
2060000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
2677000 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
2659000 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
2864000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2020000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3006000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2089000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2533000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2060000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2676000 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2648000 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2842000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-2020000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-3006000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2089000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-2533000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2060000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-2680000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-2648000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-2842000 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2013 us-gaap Depreciation
Depreciation
158000 USD
CY2014 us-gaap Depreciation
Depreciation
363000 USD
CY2013 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
22000 USD
CY2014 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
5000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
169000 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
421000 USD
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-104000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
65000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
126000 USD
CY2013 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
90000 USD
CY2014 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-74000 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-71000 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
163000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7686000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7993000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
295000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1164000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-295000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1164000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3000 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
420000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
21989000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
420000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14008000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8736000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14008000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5272000 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Registrant Name
EntityRegistrantName
Harvard Apparatus Regenerative Technology, Inc.
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001563665
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q2 dei Entity Public Float
EntityPublicFloat
73323261 USD
CY2014 dei Trading Symbol
TradingSymbol
HART
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10069676 shares
CY2013Q4 us-gaap Other Receivables
OtherReceivables
0 USD
CY2014Q4 us-gaap Other Receivables
OtherReceivables
5000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8817000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11060000 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8817000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11061000 USD
CY2014 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1000 USD
CY2013 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 USD
CY2014 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
5000 USD
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
0 USD
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
1000 USD
CY2014 hart Product Distribution Agreement Term
ProductDistributionAgreementTerm
P10Y
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
400000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4000 USD
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2020000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3006000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2089000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2533000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2060000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2842000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
0 USD
CY2014Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1612000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
27000 USD
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
9000 USD
CY2013 hart Proceeds From Investment Made By Parent Company
ProceedsFromInvestmentMadeByParentCompany
21986000 USD
CY2014 hart Proceeds From Investment Made By Parent Company
ProceedsFromInvestmentMadeByParentCompany
0 USD
CY2014Q4 hart Acquiring Percentage Of Common Stock To Exercise Of Rights Under Shareholder Rights Plan
AcquiringPercentageOfCommonStockToExerciseOfRightsUnderShareholderRightsPlan
0.2 pure
CY2012Q2 us-gaap Shares Issued
SharesIssued
100 shares

Files In Submission

Name View Source Status
0001144204-15-018746-index-headers.html Edgar Link pending
0001144204-15-018746-index.html Edgar Link pending
0001144204-15-018746.txt Edgar Link pending
0001144204-15-018746-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hart-20141231.xml Edgar Link completed
hart-20141231.xsd Edgar Link pending
hart-20141231_cal.xml Edgar Link unprocessable
hart-20141231_def.xml Edgar Link unprocessable
hart-20141231_lab.xml Edgar Link unprocessable
hart-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg1.jpg Edgar Link pending
tpg2.jpg Edgar Link pending
v404965_10k.htm Edgar Link pending
v404965_ex21-1.htm Edgar Link pending
v404965_ex23-1.htm Edgar Link pending
v404965_ex31-1.htm Edgar Link pending
v404965_ex31-2.htm Edgar Link pending
v404965_ex32-1.htm Edgar Link pending
v404965_ex32-2.htm Edgar Link pending
v404965_ex4-2.htm Edgar Link pending